Health ❯ Healthcare ❯ Patient Safety

Adverse Events

Device Malfunction Medical Interventions Self-Administration Risks Major Bleeding Device Malfunctions Injury Reporting Monitoring Hematologic Toxicity Clinical Investigations Monitoring and Investigation

CDC Links At Least 25 Illnesses to Contaminated Glutathione Injections

Federal testing points to high bacterial endotoxin levels in compounded injections, prompting recalls and regulatory warnings.

Company Recalls Three Lots of Multi‑Dose Epinephrine Vials Over Contamination Concerns

Novartis Pauses CAR‑T Autoimmune Trials After Three Deaths

Vitruvias Recalls Lot of Thyroid Tablets Over 'Superpotent' Test Results

Audit Slams French Hospital Safety Gaps, Calls for Tougher Reporting

Roche Starts Placebo-Controlled Phase 3 Trial of Elevidys to Pursue EU Approval

Structure’s Oral Obesity Pill Delivers 16.3% Placebo-Adjusted Weight Loss in Phase 2

FDA Rejects Regenxbio’s Hunter Syndrome Gene Therapy Application

Roche’s CT-388 Shows Up to 22.5% Placebo-Adjusted Weight Loss in Phase 2 as Phase 3 Nears

Recalls Expand for Abbott FreeStyle Libre 3 Sensors Over False Low Readings

FDA Issues Early Alert on Certain FreeStyle Libre 3 Sensors After False Low Readings Linked to Harm

Protara Reports Strong Interim Phase 2 Results for TARA-002 in Pediatric Lymphatic Malformations

FDA Issues Safety Alert on RF Microneedling Injuries

Low-Dose Transplant Drug Preserves Beta Cells in Young People With Type 1 Diabetes, Phase 2 Trial Finds

World Patient Safety Day 2025 Centers on Safer Care for Newborns and Children

Capsida Halts STXBP1 Gene Therapy Trial After First Pediatric Participant Dies

Iza-Bren Plus Osimertinib Delivers 100% Response in Small First-Line EGFR-Mutant NSCLC Cohort

ESC Trials Recast Antiplatelet Strategies After PCI and CABG

Tandem Diabetes Announces Urgent Medical Device Correction for t:slim X2 Pumps

Safety and Cost Concerns Fuel Push to Restrict Spinal Cord Stimulators in Australia